The utility of TP53 and PIK3CA mutations as prognostic biomarkers in salivary adenoid cystic carcinoma
Wallace, A. J.
AffiliationThe Christie NHS Foundation Trust, Manchester, United Kingdom.
MetadataShow full item record
AbstractObjectives: Despite wide excision and post-operative irradiation, loco-regional and/or metastatic recurrence is a significant clinical problem in salivary adenoid cystic carcinoma (SACC). Reliable biomarkers are required to tailor post-treatment surveillance to patients at highest risk of recurrence. We sought to determine the utility of TP53 and PIK3CA mutations as prognostic biomarkers in SACC. Materials and methods: DNA was extracted from archival tumour blocks of 145 SACC patients from 66 UK referral centres and sequenced for TP53 and PIK3CA mutations. Clinical, pathological and outcome data were analysed to determine the impact of the genomic alterations on disease recurrence and overall survival (OS). Results: TP53 and PIK3CA mutations were identified in 8% (10/121 successful analyses) and 2% (3/121) of cases, respectively. There were too few PIK3CA mutations in this cohort for informative further analysis. TP53-mutated SACC had significantly shorter median OS (5.3 vs. 16.3 years, p = 0.019) and lower 10-year survival (48% vs. 81%) compared with TP53 wild-type ACC. Solid-pattern histopathology was more frequent in TP53-mutated SACC (50% vs. 15%, p = 0.27). Conclusion: TP53-mutated recurrent and metastatic SACC was associated with shorter OS, which was significant when combined with published genomic data sets. Stratifying by TP53 status, in addition to established clinical, pathological and genomic biomarkers, may usefully inform follow-up strategy.
CitationAdderley H, Rack S, Hapuarachi B, Feeney L, Morgan D, Hussell T, et al. The utility of TP53 and PIK3CA mutations as prognostic biomarkers in salivary adenoid cystic carcinoma. Oral Oncol. 2020;113:105095.
- Prevalence and associated survival of high-risk HPV-related adenoid cystic carcinoma of the salivary glands.
- Authors: Qian X, Kaufmann AM, Chen C, Tzamalis G, Hofmann VM, Keilholz U, Hummel M, Albers AE
- Issue date: 2016 Aug
- Clinical implications of genomic profiles in metastatic breast cancer with a focus on TP53 and PIK3CA, the most frequently mutated genes.
- Authors: Kim JY, Lee E, Park K, Park WY, Jung HH, Ahn JS, Im YH, Park YH
- Issue date: 2017 Apr 25
- MicroRNA Profiling and Target Genes Related to Metastasis of Salivary Adenoid Cystic Carcinoma.
- Authors: Feng X, Matsuo K, Zhang T, Hu Y, Mays AC, Browne JD, Zhou X, Sullivan CA
- Issue date: 2017 Jul
- Expression of MIF, Beclin1, and LC3 in human salivary gland adenoid cystic carcinoma and its prognostic value.
- Authors: Li C, Chen Q, Tian Z, Li S, Gong Z, Lin Z, Wang B, Liu H
- Issue date: 2019 May
- Chemokine and Chemokine Receptor Profiles in Metastatic Salivary Adenoid Cystic Carcinoma.
- Authors: Mays AC, Feng X, Browne JD, Sullivan CA
- Issue date: 2016 Aug